Yüklüyor......
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still conce...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2018
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516871/ https://ncbi.nlm.nih.gov/pubmed/30560579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|